Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide versus ramosetron for prevention of postoperative nausea and vomiting after laparoscopic gastrointestinal tumor resection
ChiCTR2000040755Phase 4Not yet recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metoclopramide and ramosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoints: Incidence of postoperative nausea and vomiting at 24 hours, Time to first flatus and 6 more. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
metoclopramideramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2000040755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040755.